Medtech company Catalyst OrthoSciences has received FDA 510(k) clearance for its Archer Patient-Specific Instrumentation.
The shoulder arthroplasty technology is a suite of humeral and glenoid guides that helps orthopedic surgeons improve precision, consistency and confidence, according to a Feb. 25 news release from Catalyst.
Archer PSI is indicated for anatomic and reverse shoulder procedures.
The company has launched a limited market release of Archer PSI to guide optimization before a commercial launch, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.